NCT03558360 (MMS-CB) is a clinical trial of Impedance measurement in Bariatric Surgery Candidate, sponsored by Centre Hospitalier Departemental Vendee.

Who is sponsoring NCT03558360?

NCT03558360 is sponsored by Centre Hospitalier Departemental Vendee.

What drugs are being tested in NCT03558360?

Interventions in NCT03558360: Impedance measurement.

What condition does NCT03558360 study?

NCT03558360 studies Bariatric Surgery Candidate.

Is NCT03558360 still recruiting?

NCT03558360 is currently status unknown. Last updated 23 December 2021.

Last reviewed 2021-12-23 · How we verify

NCT03558360: MMS-CB

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Preoperative Dry Lean Body Mass as a Prognostic Factor for Excess Weight Loss After Bariatric Surgery.

Status unknown Last updated 23 December 2021

What this trial tests

trial testing Impedance measurement in Bariatric Surgery Candidate in 180 participants. Status unknown.

Timeline

15 October 2018

Primary endpoint
1 April 2022

1 September 2022

Quick facts

Lead sponsor	Centre Hospitalier Departemental Vendee
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	180
Start date	15 October 2018
Primary completion	1 April 2022
Estimated completion	1 September 2022
Sites	1 location across France

Drugs / interventions tested

Impedance measurement

Conditions studied

Bariatric Surgery Candidate — all drugs for Bariatric Surgery Candidate →

Sponsor

Centre Hospitalier Departemental Vendee

Who can join

Adults 18 to 65, any sex, with Bariatric Surgery Candidate. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Bariatric surgery is currently the only method that has proven long-term effectiveness in obesity. Although the benefit of physical activity on weight loss has been demonstrated, no correlation has ever been reported between preoperative lean body mass and postoperative weight loss. Dry lean mass is probably an essential prognostic factor for the effectiveness of bariatric surgery. The main objective of this study is to define a preoperative dry lean body mass threshold as a worst prognostic factor for weight loss one year after bariatric surgery. The management of patients included in this study was modelled on the management usually offered to patients followed for the same pathology in the diabeto-endocrinology department. There are no study-specific examinations that are not part of current practice.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Bariatric Surgery Candidate

Currently open trials in the same condition.

NCT07525232 — Stepwise PEEP vs Sustained Inflation in Bariatric Surgery Patients · NA · recruiting
NCT06511310 — Exercise, Brain Activity, and Weight Maintenance · NA · recruiting
NCT05966727 — Exploratory Evaluation of the Effect of Cholestyramine on Serum Levels of POPs in Obese Female Patients · NA · recruiting
NCT06915558 — Modulation of the Inflammatory Response in Bariatric Surgery · recruiting
NCT06689241 — Rivaroxaban Versus Enoxaparin for Prophylaxis of Venous Thromboembolism in Bariatric Surgery · NA · recruiting

Other Centre Hospitalier Departemental Vendee trials

Trials by the same sponsor.

NCT07489820 — Evaluation of the Efficacy of Negative Pressure Wound Therapy on Perineal Healing Following Abdominoperineal Amputation · NA · not yet recruiting
NCT07313293 — Impact of Foot Reflexology on Nausea After Obesity Surgery · NA · recruiting
NCT07314632 — Prospective Study in Laser Treatment of Pilonidal Cysts · recruiting
NCT07340060 — Statistical Association Between Bicarbonate Levels and Death or Admission to Intensive Care Within 48 Hours in Patients · recruiting
NCT07228767 — Assessment of Surgeons' Mental Fatigue Based on Operating Time · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03558360 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Departemental Vendee
Last refreshed: 23 December 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03558360.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing